Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11998600 Enhancing the therapeutic activity of an immune checkpoint inhibitor

Patent 11998600 was granted and assigned to MaineHealth on June, 2024 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

MaineHealth

Current Assignee

MaineHealth

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

119986000

Patent Inventor Names

Liangru Contois0

Peter C. Brooks0

Jennifer M. Caron0

Date of Patent

June 4, 2024

Patent Application Number

171105430

Date Filed

December 3, 2020

Patent Citations

‌

US Patent 8025883 Antagonists and methods for inhibiting angiogenesis

‌

US Patent 7122635 Method and composition for angiogenesis inhibition

‌

US Patent 7345151 Antagonists specific for denatured collagen and methods of using same

‌

US Patent 7588760 Antagonists specific for denatured collagen and methods of using same

‌

US Patent 9890208 Compositions and methods for treating inflammation and fibrosis

Patent Primary Examiner

‌

Maher M. Haddad

Patent abstract

The present invention provides antagonists and methods of use thereof in the treatment of cancer and abnormal immune suppression diseases.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11998600 Enhancing the therapeutic activity of an immune checkpoint inhibitor

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API